The presynaptic effect of beta-adrenoceptor antagonists on noradrenergic neurones.
D000313:Adrenal Medulla / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents; D004558:Electric Stimulation; D006145:Guanethidine / Q000494:pharmacology; D006325:Heart Atria / Q000294:innervation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D009474:Neurons / Q000187:drug effects; D009541:Nictitating Membrane / Q000294:innervation; D009638:Norepinephrine / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011618:Psychotic Disorders / Q000188:drug therapy; D011941:Receptors, Adrenergic / Q000378:metabolism; D013237:Stereoisomerism; D013566:Sympathomimetics / Q000037:antagonists & inhibitors; D013570:Synaptic Membranes / Q000187:drug effects*; D014202:Tremor / Q000188:drug therapy; D014649:Vas Deferens / Q000294:innervation; D014666:Vasomotor System / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D006145:Guanethidine